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OBJECTIVES: Septic pulmonary embolism caused by a Klebsiella (K.) pneumoniae liver abscess is rare but can
cause considerable morbidity and mortality. However, clinical information regarding this condition is limited.
This study was conducted to elucidate the full disease spectrum to improve its diagnosis and treatment.
METHOD: We reviewed the clinical characteristics, imaging findings, and clinical courses of 14 patients
diagnosed with septic pulmonary embolism caused by a K. pneumoniae liver abscess over a period of 9 years.
RESULTS: The two most prevalent symptoms were fever and shortness of breath. Computed tomography
findings included a feeding vessel sign (79%), nodules with or without cavities (79%), pleural effusions (71%),
peripheral wedge-shaped opacities (64%), patchy ground-glass opacities (50%), air bronchograms within a
nodule (36%), consolidations (21%), halo signs (14%), and lung abscesses (14%). Nine (64%) of the patients
developed severe complications and required intensive care. According to follow-up chest radiography, the
infiltrates and consolidations were resolved within two weeks, and the nodular opacities were resolved within
one month. Two (14%) patients died of septic shock; one patient had metastatic meningitis, and the other had
metastatic pericarditis.
CONCLUSION: The clinical presentations ranged from insidious illness with fever and respiratory symptoms to
respiratory failure and septic shock. A broad spectrum of imaging findings, ranging from nodules to multiple
consolidations, was detected. Septic pulmonary embolism caused by a K. pneumoniae liver abscess combined
with the metastatic infection of other vital organs confers a poor prognosis.
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’ INTRODUCTION
Septic pulmonary embolism (SPE) is a type of nonthrom-
botic pulmonary embolism in which a thrombus containing
microorganisms causes an inflammatory reaction (1). SPE
thrombi can cause pulmonary infarction and metastatic
abscesses. SPE is a serious but rare condition that is
challenging to diagnose. Because the clinical and radio-
graphic features at presentation are not specific, the
diagnosis of this disease is frequently delayed (2). Histo-
pathological confirmation is typically unfeasible in clinical
practice (2); thus, most SPE cases are diagnosed based on
computed tomography (CT) scan findings (2–5) and clinical
evidence of infection (2). The typical CT scan findings that
indicate SPE include peripheral nodules with or without
cavitations, a feeding vessel sign, and wedge-shaped
peripheral lesions abutting the pleura (3–5). In a systematic
review of 168 SPE patients from June 1978 to September
2012, the most pervasive causative pathogen was Staphylo-
coccus aureus, which accounted for 75 of 137 (55%) cases
with positive blood cultures. S. aureus infections were
frequent due to the use of intravenous drugs or an
intravascular indwelling catheter or to the presence of soft
tissue purulent infection. Klebsiella (K.) pneumoniae was the
most prevalent causative gram-negative pathogen, account-
ing for 11 of 137 (8%) cases with positive blood cultures.
Liver abscess was the most frequently observed primary
source of infection in SPE caused by K. pneumoniae (6).
A distinct type of invasive liver abscess syndrome caused by
community-acquired K. pneumoniae was first reported in
Taiwan in 1986 (7). During the previous two decades, this
invasive liver abscess syndrome has been increasinglyDOI: 10.6061/clinics/2015(06)03
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described in many countries (8–15) and has begun to emerge
worldwide. Metastatic infection is a characteristic feature in
this syndrome; the eyes, lungs, and central nervous system
are the most common sites of metastasis (16,17).
In a nationwide population-based study in Taiwan,
patients with a K. pneumoniae liver abscess (KPLA) had a
consistently higher incidence of extrahepatic K. pneumoniae
infection than patients without a liver abscess during the
1-year follow-up period. Among the extrahepatic K. pneu-
moniae infections, the incidence of SPE caused by a KPLA
(SPE-KPLA) was 0.5% (18), and only a few cases of SPE-
KPLA have been reported in the English-language literature
(19–22). Although SPE-KPLA is rare, it can cause consider-
able morbidity (19,21,22) and mortality (19). However, the
full spectrum of SPE-KPLA has not been well described.
Therefore, this study was conducted to elucidate the clinical
characteristics, imaging findings, and clinical courses of SPE-
KPLA patients.
’ MATERIALS AND METHODS
Patient selection
The Institutional Review Board at our hospital approved
this study. The study was conducted at the Tainan Municipal
Hospital, a 516-bed referral teaching hospital in Southern
Taiwan. We performed a computer-aided search of electronic
medical records and an imaging database and identified 221
KPLA patients diagnosed between January 2005 and
December 2013. Among the 221 patients, 14 had abnormal
chest radiographic findings, including multiple nodular
opacities (n=11) and ill-defined infiltrates (n=3). All 14
patients underwent a thoracic CT scan and follow-up chest
radiography, and two of the 14 patients underwent a follow-
up thoracic CT scan. The CT scans were obtained using two
multidetector CT scanners at our institution, including a GE
LightSpeed VCT 64-slice CT scanner (GE Healthcare,
Milwaukee, USA) and a GE BrightSpeed Elite Select 16-slice
CT scanner (GE Healthcare, Milwaukee, USA), during the
9-year period. The CT scanning parameters were as follows:
120 kV, 100 to 320 mA, 0.8-second rotation time, 5 mm slice
thickness, and 5 mm interval. The images were reviewed at a
lung window setting level of  700 Hounsfield units (HU)
and width of 1500 HU and a mediastinum window setting
level of 40 HU and a width of 350 HU. Two chest physicians
(Chou DW and Chung KM) independently evaluated the
thoracic CT findings and follow-up chest radiographs of the
14 patients. The thoracic CT findings included a feeding
vessel sign, peripheral wedge-shaped opacity, nodules with
or without cavities, patchy ground-glass opacities, air bron-
chograms within a nodule, consolidations, lung abscesses,
halo signs, and pleural effusion. Any discrepancies were
resolved by discussion with a chest radiologist (Han SC)
to reach a final consensus. The following clinical data were
collected from the 14 patients: gender, age, presented
symptoms, comorbidities, laboratory data, antimicrobial
susceptibilities, antibiotic therapy, surgical procedures, com-
plications, length of stay, and outcomes.
The inclusion criteria for the diagnosis of SPE-KPLA were
adapted from Cook et al. (2) and comprised (1) a CT scan
showing multiple nodular opacities or ill-defined infiltrates
compatible with SPE, (2) a KPLA serving as the primary
source of infection, (3) clinical and radiographic improve-
ment following antibiotic treatment, and (4) the exclusion of
other potential explanations of lung lesions.
Definitions
A case of KPLA was defined as the presence of one or
multiple liver abscesses detected by sonography or CT as
well as culture-confirmed K. pneumoniae isolated from a liver
Table 1 - Clinical characteristics, computed tomographic
findings, and clinical courses of the 14 patients with
septic pulmonary embolism caused by a Klebsiella
pneumoniae liver abscess.
Variables Value
Clinical characteristics
Sex (male/female), n 10/4
Age (y), mean and range 59.6 ±10.7 (39–80)
Interval between SPE presentation
and admission, n (%)
Day of admission 10 (71%)
p 3 days after admission 4 (29%)
Presented symptoms, n (%)
Fever 14 (100%)
Shortness of breath 8 (57%)
Cough 5 (36%)
General weakness 5 (36%)
Altered mental status 2 (14%)
Hemoptysis 2 (14%)
Right upper quadrant abdominal pain 1 (7%)
Comorbidities, n (%)
Diabetes mellitus 12 (86%)
Hypertension 2 (14%)
Cerebrovascular disease 1 (7%)
Laboratory data, n (%)
White blood cell count 4 10,000 cells/mm3 9 (64%)
Serum creatinine level 4 1.5 mg/dL 8 (57%)
Serum alanine transaminase level 4 40 IU/mL 6 (43%)
Liver abscess location, n (%)
Right lobe 9 (64%)
Left lobe 4 (29%)
Both lobes 1 (7%)
Computed tomographic findings
Feeding vessel sign 11 (79%)
Nodule
Without cavity 11 (79%)
With cavity 11 (79%)
Peripheral wedge-shaped opacity 9 (64%)
Patchy ground-glass opacity 7 (50%)
Air bronchograms within a nodule 5 (36%)
Focal consolidation 3 (21%)
Halo sign 2 (14%)
Lung abscess 2 (14%)
Pleural effusion
Bilateral 4 (29%)
Right 4 (29%)
Left 2 (14%)
Lesions in
Bilateral lungs 12 (86%)
Right lung 2 (14%)
Clinical courses
Antibiotic therapy, n (%)
Ceftriaxone combined with metronidazole 10 (71%)
Carbapenem 3 (21%)
Piperacillin/tazobactam 1 (7%)
Surgical procedures, n (%)
Pigtail catheter drainage of liver abscess 10 (71%)
Tube thoracostomy 2 (14%)
Video-assisted thoracostomy with
decortication
1 (7%)
Complications, n (%)
Acute kidney injury 8 (57%)
Septic shock 6 (43%)
Acute respiratory failure 5 (36%)
Length of stay in hospital (d), mean and range 20.9 ± 21.1 (8–42)
Mortality, n (%) 2 (14%)
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abscess aspirate or the blood. The diagnostic criteria for acute
kidney injury included an increase in serum creatinine by at
least 0.3 mg/dL within 48 hours (23). Halo sign was defined
as a ground-glass attenuation surrounding a pulmonary
nodule on the CT scan (24). Ground-glass opacity was
defined as a hazy increase in attenuation without the
obscuration of vascular markings. Consolidation was
defined as a localized increase in lung attenuation with the
obscuration of vascular markings.
’ RESULTS
Clinical characteristics
We identified 14 patients with SPE-KPLA. Table 1 lists the
clinical characteristics, CT findings, and clinical courses of the
14 patients with SPE-KPLA, all of whom were admitted
through the emergency department. Liver abscess with SPE
was diagnosed on the day of admission in 10 (71%) of the
patients and within 3 days of admission in the remaining
4 (29%) patients. Diabetes mellitus was the major underlying
disease (n=12). Of the 12 (83%) diabetic patients, 10 exhibited a
glycosylated hemoglobin value higher than 12%, 5 presented
with hyperosmolar hyperglycemia syndrome, and one pre-
sented with diabetic ketoacidosis upon admission. Among the
14 patients, the 2 most prevalent symptoms were fever and
shortness of breath. Most patients had an elevated white blood
cell count and serum creatinine level. Gas formation in the
abscess was observed in 5 (36%) of the patients.
Imaging findings
More than two imaging findings were identified for each
patient, and 12 (86%) of the patients exhibited lesions in both
lungs. The most common CT findings were a feeding vessel
sign (Figure 1A), peripheral wedge-shaped opacity (Figure 1B),
a nodule with or without a cavity (Figure 1A), and patchy
ground-glass opacities (Figure 2A). Other CT findings included
air bronchograms within a nodule (Figure 2B), focal consolida-
tions (Figure 3), lung abscesses (Figure 1A), and halo signs
(Figure 1B). Pleural effusion was observed in 10 (71%) of the
patients. Two patients who underwent a follow-up thoracic CT
scan; one exhibited new lung abscess formation (Figures 4A-B),
and the second exhibited new loculated pleural effusion
formation (Figures 4C-D). Among the 12 survivors, follow-up
chest radiography revealed that 7 patients had ill-defined
infiltrates that were resolved within 7–14 days and 8 patients
had nodular opacities that were resolved within 10–30 days.
Clinical courses
Community-acquired K. pneumoniae bacteremia was
confirmed in all 14 patients. All 38 K. pneumoniae isolates
Figure 1 - A) A lung window of a coronal computed tomography scan shows a cavitary nodule (arrow) with a feeding vessel sign
(arrowhead) and lung abscess (curved arrow) in the right upper lobe. B) A lung window of a cross-sectional computed tomography scan
shows a peripheral wedge-shaped opacity (arrow) and ground-glass attenuation surrounding a pulmonary nodule (arrowhead) in the
left upper lobe.
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(28 from the blood and 10 from liver abscess aspirates) were
susceptible to cephalosporins, aminoglycosides, carbapenem,
and levofloxacin. Six isolates (4 from the blood and 2 from
liver abscess aspirates) from two of the patients were
resistant to ampicillin/sulbactam. Three isolates (2 from the
blood and one from a liver abscess aspirate) from one of the
patients were resistant to piperacillin. All 38 isolates
expressed the hypermucoviscous phenotype. Bacterial cul-
tures of sputum (n=9) or endotracheal aspirates (n=5)
showed negative results. Antibiotic therapy was initiated
on the day of admission and was administered for 2–6
weeks.
Among the 14 patients, 10 underwent pigtail catheter
drainage of the liver abscess, 4 had an immature liver abscess
and did not receive drainage, 2 had massive pleural
effusions, one had a loculated pleural effusion that occurred
one week after SPE treatment, two underwent tube
thoracostomy for massive pleural effusions, and one under-
went video-assisted thoracostomy with decortications for a
loculated pleural effusion. The pleural effusions of the three
patients were serosanguinous in appearance and were
exudates predominated by neutrophils.
Nine (64%) patients developed severe complications,
including acute kidney injury, septic shock, and acute
respiratory failure, within 7 days of SPE presentation and
were admitted to the intensive care unit (ICU). The mean
Acute Physiologic and Chronic Health Evaluation II score
during the first 24 hours after ICU admission was 14 (range:
10 to 20). The mean ICU length of stay was 15.5±12.2 days.
Two patients died during hospitalization, representing an
in-hospital mortality of 14%. These two patients died of
refractory shock; one had septic metastatic meningitis, and
the other had septic metastatic pericarditis (Figures 5A-C).
The follow-up duration of the 12 survivors after hospital
discharge ranged from 3 to 48 months, and none of the
survivors had complications resulting from SPE-KPLA.
’ DISCUSSION
In this study, SPE-KPLA was diagnosed in 14 of the 221
(6%) patients, which is consistent with the rate of 4.5% (5 of
110 patients) reported by a previous study (16). However,
several tiny nodules were not observed in chest radiographs
and were only detected in thoracic CT scans. Therefore, the
Figure 2 - A) A lung window of a cross-sectional computed tomography scan shows multiple patchy ground-glass opacities (arrows) in
the right lung. B) A lung window of a cross-sectional computed tomography scan shows air bronchograms within a nodule (arrow) in
the left lung.
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prevalence of SPE-KPLA may have been underestimated
because thoracic CT scans were performed only on the
14 patients with abnormal chest radiographic findings.
Among the 12 diabetic SPE-KPLA patients, 10 (83%)
exhibited glycosylated hemoglobin values higher than 12%,
indicating that poor glycemic control was highly associated
with septic metastatic infection. The two most prevalent
symptoms were fever and shortness of breath. Only one
patient complained of abdominal pain upon admission. The
absence of abdominal pain was likely due to hypoesthesia
caused by diabetic polyneuropathy. Establishing an SPE-
KPLA diagnosis in diabetic patients can be challenging
without pathognomonic physical findings. Thus, a high
index of suspicion is crucial for early recognition. When
diabetic patients present with fever and shortness of breath,
and abnormal chest radiograph findings reveal multiple
nodular opacities and ill-defined infiltrate patterns, abdom-
inal sonography should be performed to eliminate the
possibility of a liver abscess. Additionally, 70% of the SPEs
were present upon admission, and 30% occurred within
3 days of admission, indicating that SPEs can occur
fulminantly. New SPE formation occurred despite perform-
ing broad-spectrum antibiotic therapy and pigtail catheter
drainage of the liver abscess for more than one week,
indicating that SPEs could not be prevented.
All K. pneumoniae isolates were susceptible to cephalospor-
ins, aminoglycosides, and levofloxacin, and susceptibility to
ampicillin/sulbactam and piperacillin varied. No nosoco-
mial or multiresistant strains were identified. In this study,
which examined patients treated between 2005 and 2013, the
pattern of antimicrobial susceptibility was similar to that
reported by a previous study involving patients treated
between 1990 and 1996 (8). Remarkably, the antimicrobial
susceptibility pattern of K. pneumoniae, which causes
community-acquired liver abscesses, has remained unchan-
ged in Taiwan over the past 20 years. This is the case because
the K. pneumoniae strain that causes liver abscesses is
community-acquired and is not naturally a multiresistant
strain (8). In this study, all K. pneumoniae isolates expressed
the hypermucoviscous phenotype. Hypermucoviscosity has
Figure 3 - A) A chest radiograph reveals multiple alveolar consolidations, predominantly in the upper lung zones. B) A lung window of
a coronal computed tomography scan shows multiple consolidations with air bronchograms (arrows) in the upper lobes. Additionally,
a nodule with a feeding vessel sign (arrowhead) is shown. C) A lung window of a cross-sectional computed tomography scan shows
multiple peripheral wedge-shaped (arrowheads) and D) nodular (arrowheads) opacities in the bilateral lungs.
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been correlated with a high level of resistance to complement-
mediated serum killing (25). The hypermucoviscous phenotype
of K. pneumoniae bacteremic isolates has been associated with
the development of a distinctive invasive syndrome (26). The
hypermucoviscous phenotype of the capsular serotype K1 has
been reported as a major virulence factor of K. pneumoniae that
causes primary liver abscess and septic metastatic complica-
tions (27,28). Clinicians should therefore initiate aggressive
investigations for invasive diseases when the hypermucovis-
cous phenotype is identified.
In this study, protean presentations of SPE-KPLA ranged
from insidious illness with fever and respiratory symptoms
such as shortness of breath, cough, and hemoptysis to
respiratory failure and septic shock. Among the nine patients
who required ICU care, seven patients recovered without
septic metastasis to other vital organs, and two patients died
from septic metastasis to other vital organs; one of the
patients had septic metastatic meningitis and died on Day 42
following admission as a result of refractory shock and
multiple organ failure, and the other had septic metastatic
pericarditis without cardiac tamponade and died on Day 8
following admission due to refractory shock. Thus, SPE
combined with metastatic infection of other vital organs
confers a poor prognosis.
In SPE, the microembolism is not directly observed on CT
images, and diagnosis relies on lung parenchymal findings.
Indirect signs of SPE include pulmonary edema, infarction,
empyema, and pulmonary hypertension (1). In this study, a
broad spectrum of CT findings was detected, varying from
nodules to multiple consolidations. Typical CT findings
indicative of SPE-KPLA included peripheral nodules with or
without cavities, a feeding vessel sign, and peripheral
wedge-shaped opacities, all of which have been previously
reported (18–21). However, previous studies have not
comprehensively described the halo sign, patchy ground-
glass opacities, and multiple focal consolidations in SPE-
KPLA. The halo sign pathologically represents hemorrhagic
pulmonary nodules, tumor cell infiltration, or nonhemor-
rhagic inflammatory lesions. Hemorrhagic pulmonary
nodules may occur in infectious diseases, including invasive
pulmonary aspergillosis, mucormycosis, and candidiasis (29).
Although a halo sign is not specific, it enables most
hemorrhagic pulmonary nodules to be distinguished from
nonhemorrhagic nodules (30,31). Ground-glass opacities
Figure 4 - A) A lung window of a cross-sectional computed tomography scan shows patchy ground-glass opacities in the left lower lobe
(arrow). B) A repeat computed tomography scan obtained in the same image plane 7 days later shows new bilateral lung abscess
(arrowheads) and pleural effusion (asterisks) formation. C) A lung window of a cross-sectional computed tomography scan shows a
peripheral wedge-shaped opacity in the right middle lobe (arrow). D) A repeat computed tomography scan obtained in the same
image plane 12 days later shows interval regression of the peripheral wedge-shaped opacity. A new left loculated pleural effusion
(asterisk) formation is observed.
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may be caused by alveolar hemorrhage, cytomegalovirus
pneumonia, Pneumocystis carinii pneumonia, and bronchio-
litis obliterans with organizing pneumonia (32). The presence
of parenchymal consolidation in pulmonary infarction is
primarily caused by pulmonary hemorrhage (33). The
endothelial cells of the capillaries and arterioles as well as
the venules of the lungs are highly susceptible to hypoxia.
Therefore, mild transient ischemia of lung tissue may result
in marked vessel dilation as well as increased vascular
permeability with fluid and erythrocyte leakage (34). In this
study, hemoptysis was observed in patients with CT findings
revealing patchy ground-glass opacities and multiple focal
consolidations indicating pulmonary hemorrhage.
Two limitations were encountered while conducting this
study. First, we retrospectively evaluated only those patients
who underwent thoracic CT scans, which may have resulted
in selection bias. Additionally, because the patient sample
was relatively small, we could not identify statistically
significant predictors of mortality. A larger sample is
required to generalize our findings with greater confidence
(although SPE-KPLA cases remain exceptionally rare).
Second, no histopathological confirmation was associated
with the CT findings. Because histopathological confirmation
was unfeasible, the current SPE diagnosis was based on CT
findings and clinical evidence of infection. Despite this
shortcoming, we believe that the CT findings and subsequent
clinical courses allowed the diagnosis to be made with
confidence.
The main findings of this study are summarized as
follows. First, the clinical presentations ranged from
insidious illness with fever and respiratory symptoms to
respiratory failure and septic shock. Second, a broad
spectrum of imaging findings was detected, ranging from
nodules to multiple consolidations. Finally, SPE-KPLA
combined with the metastatic infection of other vital organs
poses a poor prognosis.
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